Spherusol Market Report 2026

Spherusol Market Overview

• The Spherusol market growth in the historic period has been driven by improved understanding of coccidioidomycosis epidemiology, historical reliance on serological diagnostics • Market expansion is supported by growing investment in infectious disease surveillance, rising demand for early exposure detection tools • Growth Driver: Impact Of Rising Coccidioidomycosis Incidence On Market Growth • North America was the largest region and fastest growing region.

What Is Covered Under Spherusol Market?

Spherusol is a diagnostic skin test designed to identify delayed-type hypersensitivity (DTH) reactions due to exposure to coccidioides fungi. These fungi cause valley fever (coccidioidomycosis). The test evaluates past infections and immune responses, but it is not intended for diagnosing current infections. The main indications for spherusol are pain management, infection control, neurological disorders, and oncology. Pain management involves the use of various treatments and diagnostic tools to alleviate and manage chronic pain. This can include medications, physical therapy, and specific diagnostic tests. In the case of spherusol, it is used in cases where the pain is associated with coccidioidomycosis, a fungal infection that can cause severe symptoms, including pain in the chest, joints, and muscles. It is distributed through various channels such as hospitals pharmacies, retail pharmacies, and online pharmacies and is utilized by hospitals, diagnostic laboratories, and research institutions.

What Is The Spherusol Market Growth Forecast?

The growth in the forecast period can be attributed to growing investment in infectious disease surveillance, rising demand for early exposure detection tools, expansion of diagnostic testing in endemic regions, increasing research into immune response diagnostics, broader adoption of preventive healthcare diagnostics. Major trends in the forecast period include increasing adoption of advanced diagnostic skin tests, rising focus on early immune response detection, growing use of dth-based diagnostic tools, expansion of fungal infection surveillance programs, enhanced clinical emphasis on epidemiological screening.

Global Spherusol Market Segmentation

1) By Indication: Pain Management, Infection Control, Neurological Disorders, Oncology 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies 3) By End-User: Hospitals, Diagnostic laboratories, Research institutions

What Are The Drivers Of The Spherusol Market?

The rise in incidence of coccidioidomycosis (valley fever) is expected to fuel the growth of the spherusol market going forward. Coccidioidomycosis, or valley fever, is a fungal disease caused by the coccidioides fungus, found in dry, sandy soils. It mainly impacts the lungs and can spread to other areas of the body, through inhaling fungal spores. Coccidioidomycosis is increasing due to factors such as climate change, which creates warmer and drier conditions favorable for the coccidioides fungus, as well as population growth in endemic areas, leading to more human exposure. Spherusol helps diagnose coccidioidomycosis by using a skin test to detect hypersensitivity to coccidioides immitis. The test measures the reaction at the injection site after 48 hours to identify prior exposure to the fungus. For instance, in August 2025, according to The California Department of Public Health (CDPH), a US-based government agency, in California continues to see escalating Valley fever burden, with more than 5,500 provisional cases recorded in the first half of 2025 following nearly 12,500 reported cases in 2024, signaling a sustained upward trend in disease incidence across the state. Therefore, the rise in incidence of coccidioidomycosis (valley fever) is driving the growth of the spherusol industry. The rise in outdoor activities is expected to propel the growth of the spherusol market going forward. Outdoor activities are recreational or physical pursuits conducted in open spaces, or in nature. Outdoor activities are rising as people seek physical exercise, mental well-being, and a break from technology, driven by health benefits and social media trends. Outdoor activities expose individuals to allergens, and spherusol helps manage allergic reactions by desensitizing the immune system. For instance, in June 2024, according to the Outdoor Industry Association, a US-based non-profit organization, organization outdoor recreation expanded in 2023, with the participant base increasing by 4.1% to an all-time high of 175.8 million people, representing 57.3% of the national population. Therefore, the rise in outdoor activities will drive the growth of the spherusol industry. The rise in the aging population is expected to propel the growth of the spherusol market going forward. An aging population refers to individuals aged 65 and older, who experience various age-related changes such as reduced skin elasticity, wrinkles, and fine lines. The increase in the aging population is due to factors such as improved healthcare, better living standards, and advances in medical treatments that have led to longer life expectancies. Spevigo is used in the geriatric population to manage generalized pustular psoriasis, offering effective treatment for older adults with this severe condition. For instance, in January 2024, according to a report published by the Population Reference Bureau, a US-based non-profit organization, the number of Americans aged 65 and older is expected to rise from 58 million in 2022 to 82 million by 2050, marking a 47% increase. As a result, this age group’s proportion of the total U.S. population will grow from 17% to 23% during this period. Therefore, the rise in the aging population will propel the growth of the spherusol industry.

Key Players In The Global Spherusol Market

Major companies operating in the spherusol market are Nielsen Biosciences Inc.

Regional Insights

North America was the largest region in the spherusol market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Spherusol Market?

The spherusol market consists of sales of skin test antigens, which include sterile solutions and injections. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Spherusol Market Report 2026?

The spherusol market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the spherusol industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.